NCT00426543View on ClinicalTrials.gov

Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

August 31, 2010

Conditions
Primary Sjögren's SyndromeXerostomiaHyposalivationKeratoconjunctivitis SiccaFatigue
Interventions
DRUG

MabThera (rituximab)

1000 mg infusion twice with 14 days interval

DRUG

Rituximab, Mabthera

1000 mg Rituximab infusion in 500 ml isotonic sodiumchloride twice with 14 days interval

Trial Locations (1)

2200

Institute of Odontology, Faculty of Health Sciences, University of Copenhagen, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

University of Copenhagen

OTHER

NCT00426543 - Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome | Biotech Hunter | Biotech Hunter